Literature DB >> 22528874

Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.

Jianghua Zheng1, Dan Xiong, Xueqing Sun, Jinglong Wang, Mingang Hao, Tao Ding, Gang Xiao, Xiumin Wang, Yan Mao, Yuejie Fu, Kunwei Shen, Jianhua Wang.   

Abstract

Hypermethylated in cancer 1(HIC1) was identified as a strong suppressor gene in chromosome region 17p13.3 telomeric to TP53. This gene encodes a transcriptional repressor and is ubiquitously expressed in normal tissues but downexpressed in different tumor tissues where it is hypermethylated. The hypermethylation of this chromosomal region leads to epigenetic inactivation of HIC1, which would prompt cancer cells to alter survival and signaling pathways or specific transcription factors during the period of tumorigenesis. In vitro, HIC1 function is mainly a sequence-specific transcriptional repressor interacting with a still growing range of histone deacetylase(HDAC)-dependent and HDAC-independent corepressor complexes. Furthermore, a role for HIC1 in tumor development is firmly supported by Hic1 deficient mouse model and two double heterozygote models cooperate with p53 and Ptch1. Notably, our findings suggest that potential factors derived from tumor microenviroment may play a role in modulating HIC1 expression in tumor cells by epigenetic modification, which is responsible for tumor progression. In this review, we will describe genomic and proteinic structure of HIC1, and summary the potential role of HIC1 in human various solid tumors and leukemia, and explore the influence of tumor microenviroment on inducing HIC1 expression in tumor cells.

Entities:  

Year:  2012        PMID: 22528874      PMCID: PMC3460058          DOI: 10.1007/s12307-012-0103-1

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  79 in total

1.  HIC1 hypermethylation is a late event in hematopoietic neoplasms.

Authors:  J P Issa; B A Zehnbauer; S H Kaufmann; M A Biel; S B Baylin
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

Review 2.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

Review 3.  Pharmaco-epigenomics: discovering therapeutic approaches and biomarkers for cancer therapy.

Authors:  B Claes; I Buysschaert; D Lambrechts
Journal:  Heredity (Edinb)       Date:  2010-04-14       Impact factor: 3.821

4.  Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53.

Authors:  C Guerardel; S Deltour; S Pinte; D Monte; A Begue; A K Godwin; D Leprince
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

5.  Altered neural cell fates and medulloblastoma in mouse patched mutants.

Authors:  L V Goodrich; L Milenković; K M Higgins; M P Scott
Journal:  Science       Date:  1997-08-22       Impact factor: 47.728

6.  Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.

Authors:  H Stöcklein; J Smardova; J Macak; T Katzenberger; S Höller; S Wessendorf; G Hutter; M Dreyling; E Haralambieva; U Mäder; H K Müller-Hermelink; A Rosenwald; G Ott; J Kalla
Journal:  Oncogene       Date:  2007-11-05       Impact factor: 9.867

7.  The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.

Authors:  Mathias Jenal; Emmanuelle Trinh; Christian Britschgi; Adrian Britschgi; Vincent Roh; Stephan A Vorburger; Andreas Tobler; Dominique Leprince; Martin F Fey; Kristian Helin; Mario P Tschan
Journal:  Mol Cancer Res       Date:  2009-06-02       Impact factor: 5.852

8.  The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif.

Authors:  Sophie Deltour; Sébastien Pinte; Cateline Guerardel; Bohdan Wasylyk; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

9.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

10.  p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3.

Authors:  M M Wales; M A Biel; W el Deiry; B D Nelkin; J P Issa; W K Cavenee; S J Kuerbitz; S B Baylin
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

View more
  17 in total

1.  Aberrant methylation of hypermethylated-in-cancer-1 and exocyclic DNA adducts in tobacco smokers.

Authors:  Marco E M Peluso; Armelle Munnia; Valentina Bollati; Petcharin Srivatanakul; Adisorn Jedpiyawongse; Suleeporn Sangrajrang; Marcello Ceppi; Roger W Giese; Paolo Boffetta; Andrea A Baccarelli
Journal:  Toxicol Sci       Date:  2013-10-23       Impact factor: 4.849

Review 2.  CRISPR Technology in Cancer Diagnosis and Treatment: Opportunities and Challenges.

Authors:  Behrouz Shademan; Sepideh Masjedi; Vahidreza Karamad; Alireza Isazadeh; Fatma Sogutlu; Mohammad Hosein Saeedi Rad; Alireza Nourazarian
Journal:  Biochem Genet       Date:  2022-01-29       Impact factor: 2.220

3.  Culturing conditions highly affect DNA methylation and gene expression levels in MCF7 breast cancer cell line.

Authors:  Lama Hamadneh; May Al-Majawleh; Yazun Jarrar; Sawsan Shraim; Mariam Hasan; Basha'er Abu-Irmaileh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-04-09       Impact factor: 2.416

Review 4.  Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects.

Authors:  Mohammad Mijanur Rahman; Trygve O Tollefsbol
Journal:  Methods       Date:  2020-04-18       Impact factor: 3.608

5.  Development and function of smooth muscle cells is modulated by Hic1 in mouse testis.

Authors:  Aya Uchida; Sadman Sakib; Elodie Labit; Sepideh Abbasi; R Wilder Scott; T Michael Underhill; Jeff Biernaskie; Ina Dobrinski
Journal:  Development       Date:  2020-07-13       Impact factor: 6.862

6.  Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells.

Authors:  Ji-Hong Lim
Journal:  BMB Rep       Date:  2014-07       Impact factor: 4.778

7.  Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.

Authors:  Pei Li; Xiang Liu; Zi-Ming Dong; Zhi-Qiang Ling
Journal:  Oncotarget       Date:  2015-11-10

8.  Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis.

Authors:  Anshika N Singh; Neeti Sharma
Journal:  Onco Targets Ther       Date:  2017-10-10       Impact factor: 4.147

9.  Transcription Factor and lncRNA Regulatory Networks Identify Key Elements in Lung Adenocarcinoma.

Authors:  Dan Li; William Yang; Jialing Zhang; Jack Y Yang; Renchu Guan; Mary Qu Yang
Journal:  Genes (Basel)       Date:  2018-01-05       Impact factor: 4.096

10.  Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy.

Authors:  Yuan Dong; Weiwei Yan; Shi-Long Zhang; Mu-Zi-He Zhang; Yan-Ping Zhou; Hai-Hui Ling; Meng Ning; Yanling Zhao; Ang Huang; Ping Zhang
Journal:  Oncotarget       Date:  2017-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.